How should we use ctDNA to Treat Patients with Advanced Colon and Pancreatic Cancer?
Questions & Discussion
Friday, March 22, 2024
11:57am – 12:00pm ET
Location: SSO HUB: Immuno-Oncology Zone
Multiple technologies are now available and being used to measure circulating tumor DNA in our patients. The purpose of this session is to understand how these work, the most recent data on their use for advanced colon cancer and pancreatic cancers, what the results mean, and how they can provide guidance on surgical decisions and timing of surgery.